Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease Notice to Contributors

 

Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease was founded in June 1993. It is supervised by the Health Commission of Hebei Province and sponsored by Hebei Institute of Medical Information. It is a comprehensive academic journal of heart, brain, lung, vascular disease and clinical medicine in China, a series of practical journals in China, and a journal of the Chinese Medical Journal Network. This is a monthly issue. International Standard Serial Number: ISSN 1008-5971, CN Serial Numbering: CN 13-1258/R. It is a core journal of Chinese science and technology (a statistical source journal for Chinese scientific and technological papers) .

The purpose of this journal: Focusing on the whole person's health, it focuses on the clinical scientific research achievements of major diseases and prominent problems in the fields of heart, brain, lung, vascular and related fields/interdisciplinary fields, emphasizing both internal and external importance and practical application.

Set up columns: commentary/expert forum, specialized research on heart, brain, lung, and vascular diseases, guidelines and standards, monographs, hot topics, medication guidance, comparative study of therapeutic effects, investigation research, new progress, medical evidence-based, methodological research, rehabilitation and nursing, integrated research of traditional Chinese and Western medicine, patented technologies, diagnosis and treatment analysis, etc.

 

Submission Guidelines

 

1. Main research types published　Clinical randomized controlled trials, cohort studies, case-control studies, current status surveys, reviews and systematic reviews, etc.

 

2. Publication focus　Research on related topics in the field of cardiac, cerebral, pulmonary and Vascular disease.

 

3. Green channel

3.1　In order to further promote the development of the journal, improve the level of publication, and meet the scientific research needs of the most clinical medical stuff and medical researchers, the Journal has opened a green channel for clinical or scientific research papers with significant influence and/or guidance. Those who meet one of the following conditions can apply for access to the green channel: (1) National Natural Science Foundation and major research projects of China (please provide the copy of the fund project approval) ; (2) Forward-looking or innovative papers has been confirmed to have international or domestic leading standards and needs to be published as soon as possible (please provide "new search reports" issued by libraries or medical information institutes at or above the provincial level); (3) academician and chief scientist project papers; (4) Provincial fund papers (Please provide a copy of the fund project approval); (5) Major special research topics in the field of cardiac, cerebral, pulmonary and Vascular disease; (6) Patented or applied research papers (for patents, please provide a copy of the patent approval); (7) Excellent or award-winning doctoral graduate thesis (please provide a recommendation letter from the supervisor); (8) Systematic interpretation and in-depth study of a specific disease/a group of disease laws (consisting of 3~6 articles).

Any paper that meets the requirements of the Green Channel will be reviewed by the editorial department within 10-20 working days and the comments on manuscript will be given within 2 to 3 months after the editorial approval is approved for publication. The editorial department is responsible for recommending the project host/main participant to the editorial board to become the editorial board/review expert of this journal, enjoy many preferential policies of this journal, and the editorial department of scientific and technological achievement award winners is responsible for publishing award news and subsequent follow-up . Please add a "Green Channel" before the title of the manuscript and upload relevant documents as required.

 

3.2　Please provide the following research information for fund project papers:

●Fund Statement: Indicate the name and number of the funded project.

●Author contribution: Indicate how each author participated in this research (responsible for work during the research process, assigning projects, etc.).

●Transparency Statement for Research Literature: To accept the published topic papers, the author must attach a transparency statement to prove that the report of this paper on the research is true, accurate and transparent, no important content is omitted, and any inconsistency with the research plan is explained; it is recommended to register for clinical trials and indicate the clinical trial registration number in the article.

●Conflict of interest statement: Once accepted for publication, each article must have a conflict of interest statement, and all authors must agree to the statement of conflict of interest.

●Ethics requirements: The research needs to be approved by the ethics committee of the unit. In some cases, those who have not applied for the approval of the ethics committee must indicate the reason.

●Article summary: (1) The main points of the article: the description or hypothesis of the research topic; (2) the key information: reflects the characteristics or importance of the research information; (3) the innovations and deficiencies of the research.

 

4. Publication ethics requirements　For each manuscript to be published, it is necessary to review whether there are any academic ethical issues that violate scientific research and publishing rules, focusing on the following aspects: (1) Academic misconducts including plagiarism, tampering, forgery, duplicate submission, one academic achievement multiple papers published: Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease uses Wanfang and CNKI's academic misconduct detection system to double-check each manuscript, and the manuscripts that meet the following requirements can be stored in the database, and carry out the follow-up trial work: ① For original papers, the copy ratio should not exceed 10%; ②For review papers, the copy ratio should not exceed 20%; ③For topic papers, multiple papers can be published according to different research stages on the same topic. Usually, the research objects and observation indicators in these papers will exist in different papers, but the copy ratio of the author's own papers should not exceed 20%. If a reader informs the editorial department that a paper is plagiarized after publication, the editorial department will contact the competent leader of the author's work unit according to the evidence provided by the reader. (2) When the reviewer suspects that there are false data in the paper, the editorial department will communicate with the author. If the author provides the original data or research records and proves that there is no forgery, the review can continue. (3) Change of author's signature: The person responsible for the paper must clearly explain the reason for the change of the author's signature, and submit to the editorial department a statement from all authors expressing their consent to the addition or deletion of an author. The statement should list each author's own research and contribution to the paper. The editorial department will review the reasons for the change. If there is deception or misconduct, the editorial department will not change it. (4) Author's contribution: When submitting a manuscript, it is necessary to indicate the work and assignment of each author during the research process. (5) Statement of conflict of interest: when submitting a manuscript, it is necessary to declare in the manuscript whether there is any conflict of interest. (6) Before the publication of the paper, the editorial department keeps the content of the paper confidential and cannot be used for other purposes. If an author reports that the relevant reviewer has misappropriated the content or data of the author’s paper, the editorial department will permanently cancel it after the investigation and verification of the identity of the reviewer.

 

5.Selected databases　(1) Chinese core journals of science and technology (Chinese scientific and technological papers statistical source journals ); (2) RCCSE Chinese core academic journals (A) ; (3) Chinese biomedical core journals; (4) Chinese academic journals comprehensive evaluation database source journals; (5) China Journal Full-text Database (CNKI) ; (6) Wanfang Digital Journal Full-text Database (Wanfang) ; (7) Chinese Science and Technology Journal Database (VIP) .

 

6. How to submit manuscripts　Please log on to the official website of Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease for online submission. The specific steps are as follows:

(1) Log in to the official website of Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease (http://www.syxnf.net): After logging in, click "Author's Contribution" to register.

(2) Registration: After clicking "register", fill in the registration information as required. Please be sure to fill in the real and valid information, otherwise it will affect the processing flow of the manuscript. The items marked with red "*" are required. After filling in, click "Submit ". Complete registration, click Back to log in.

(3) Contribution: Click "I want to submit" and fill in the manuscript information in detail. Upload the manuscript and the paper recommendation letter affixed with the official seal of the unit (please go to the download center of the journal's official website to download the template), and click "send" after uploading to complete the submission.

 

7.Guidelines for paper writing　the following corresponding guidelines should be followed during the paper writing process, and the guidelines should be used to guide the completion of the paper structure.

——CONSORT (Consolidated Standards of Reporting Trials) statement: Reporting specifications for randomized controlled trials. The statement follows the principle of different reporting methods for different types of medical research, and is mainly aimed at two parallel randomized controlled trials, cluster trials, non-inferiority and equivalence trials, live trials, traditional Chinese medicine and herbal interventions, non-drug treatments, acupuncture, adverse reactions and other clinical randomized controlled trials. The statement uses 25 checklists and a flow chart to standardize the writing of randomized controlled trials. In addition, the article should put the clinical trial registration number and the registration agency of the randomized controlled trial on the last line of the abstract. For more details: http://www.consort-statement.org/

——MOOSE (Reporting Checklist for Authors, Editors, and Reviewers of Meta-analyses of Observational Studies) statement: Meta-analysis reporting specifications for genetic association studies and observational studies in epidemiology.

——STARD (Standards for the Reporting of Diagnostic Accuracy Studies) statement: Reporting specifications for diagnostic test accuracy studies. For details, please visit: http://www.stard-statement.org

——STREGA (Strengthening the Reporting of Genetic Associations) statement: Applicable to the reporting norms of genetic correlation research. For more details on: http://www.strega-statement.org

——STROBE (Strengthening the Reporting of Observational Studies in Epidemiology) statement: Reporting norms for observational epidemiological studies. For more details on: http://www.strobe-statement.org

——PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-analysis: the PRISMA Statement) statement: applicable to systematic reviews and Meta-analysis. For more details: http://www.prisma-statement.org

 

Requirements for the manuscript

 

1. Peer review (external review)　This journal implements a three-review system based on peer review (initial editorial review, external expert review, and final review by the editor-in-chief). After the initial review by the editor, each paper must be sent to one or more experts for blind review. The reviewers are domestic academic peers. All papers published in the journal must undergo rigorous peer review. The editorial department will determine the revision, re-review, acceptance or acceptance of the manuscript within 2 months after the author submits the manuscript based on the peer review and the editor’s final review comments.

 

2. Medical ethics issues and informed consent　 When the main body of the paper is based on human subjects, the author should provide approval documents from the relevant ethics committee or explain the informed consent of the subjects and their relatives in the paper.

 

3. Conflict of interest　When a conflict of interest is involved in the process of research or publication of a paper, the author must attach a statement of conflict of interest.

 

4. Funds and award-winning manuscripts　If the subject is a national, ministerial, or provincial-level fund or research project, the footnote should be footnotes on the bottom left of the title page, such as “Fund Project: National Natural Science Foundation of China Funded Project (No. ×××) ”. A copy of the certificate of the funded project is attached, and the author needs to inform the research-related/potential conflict of interest. This journal has a Green Channel for fund project papers. Priority is given to fund project supporting papers. The author must be a project participant.

 

5. Title　The title of the essay strives to be concise and eye-catching, and can accurately reflect the theme of the thesis. Generally speaking, the Chinese title should be within 20 Chinese characters. It is best not to have a subtitle. Generally, there are no punctuation marks and abbreviations.

 

6. Author's signature　The name of the author is arranged in order under the title, and the order should be determined at the time of submission, and no changes should be made during the editing process; the name of the author's unit (specific to the department) and postal code are noted below the author's name. If there are two or more authors, the corresponding author should be marked and the corresponding author’s E-mail should be provided.

 

7. Abstract　The work should be accompanied by a structured Chinese and English abstract, including purpose, methods, results (main data should be given) , and conclusions. It should be written in the third person, without figures, tables, references, comments and explanations. The English abstract should include the title, the names of all authors (Chinese pinyin, each letter of the surname is capitalized, the first letter of the first name is capitalized) , the name of the unit, the city, the postal code and the name of the country. Papers in other genres, such as summaries, case reports, etc., must be accompanied by an indicative Chinese and English abstract. The English abstract generally corresponds to the content of the Chinese abstract.

 

8. Key words　The work should be indexed with 3 to 8 key words, and necessary words related to the central issue of this research or discussion should be selected from the title, abstract, and main text. Please try to use the vocabulary listed in the medical thesaurus (MeSH) in the latest edition of "Index Medicus" published by the National Library of Medicine.

 

9. Text　Please reduce the structure level as much as possible. Generally, it should not exceed 4 levels. No punctuation marks should be used after the number sequence number of the level, but one character should be left blank. The format is as follows:

1　△△△△△ (top grid)

1.1　△△△△△ (top grid)

1.1.1　△△△△△ (top grid)

1.1.1.1　△△△△△ (top grid)

9.1. Preface　The preface should focus on summarizing the research background, theoretical basis, research ideas, research methods, expected results and significance, etc., and must clearly state the purpose of this research.

9.2. Materials and methods

9.2.1. Research object: (1) When the research object is a human, it is necessary to describe the source of the cases and controls, the time for collecting the case and control, the inclusion and exclusion criteria of the research object, and the baseline data; (2) When the research object is a laboratory animal, the animal needs to be stated Name, species, cleanliness level, quantity, source (including animal certificate number) , gender, age, body mass, breeding conditions and health status, etc.

9.2.2. Research design: papers should indicate the type of research design and main methods, such as survey design (such as prospective, retrospective, cross-sectional research, etc.) , experimental design (such as self-matching design, group design, crossover design, analysis due to design, orthogonal design, etc.) , clinical trial design (specify the phase of the clinical trial, what kind of blinding method, etc.) ; it is necessary to inform how to control the interference and influence of important non-trial factors. Randomized controlled studies need to specify the specific randomization method, and cannot simply use the word "random" to describe.

9.3. Results　Should focus on summarizing important research results, seeking truth from facts, accurate data, and conclusive statements should not be confused with the content of the discussion. When reflecting the result with data, not only the derivative (percent) should be described, but the absolute number on which the derivative is calculated should also be given at the same time. The data should be statistically processed, and specific test statistic values should be given, for example: t=2.565, P=0.011.

9.4. Discussion　The discussion section should include the following contents: (1) Summary: summarize the results; (2) Interpret the results: analyze the possible causes or mechanisms of the results; (3) compare with previous literature and research: compare the results of this research with other researchers compare the research results of the same issue and discuss the reasons for the differences;

9.5. Conclusion/Closing remarks　(1) Conclusion: extracting and summarizing research findings and arguments; (2) Conditions of application of the findings: Explain the population or clinical conditions to which this result is applied; (3) Research limitations: Clarify the limitations of the research, analyze the possible causes and impacts of bias, confounding, and errors, in order to enhance the credibility of the research results; (4) Reaffirm the value of the research:  Reaffirm the value or potential value of the results to science and clinics.

9.6. Requirements for references

9.6.1. Documents in the past 5 years that the author has personally read must be the main source, and should be verified against the original text. "Internal materials", "documents to be published" and "conference materials" should not be introduced as references.

9.6.2. According to GB/T 7714-2015 "Information and Literature References Description Rules", sequential coding system is adopted for cataloging, and its serial number shall be marked with Arabic numerals in the order of appearance in the text, enclosed in square brackets, and placed on the upper right angle. The description of the references at the end of the article is sorted by Arabic numerals in the order of citation in the article, for example: [1] , without punctuation or spaces after the serial number. For the authors in the reference, all 1 to 3 are listed, and 3 or more are listed only in the top 3, followed by "etc." or "et al". Abbreviations are used for the names of foreign journals, and the format in "Index Medicus" shall prevail; for Chinese journals, the full name shall be used. The beginning and ending pages of each reference must be recorded. Documents marked with DOI can be listed at the end of the document DOI.

9.6.3. Each reference should be marked with English capital letters after the title of the document type and enclosed in square brackets, such as: ordinary books (monographs) [M] , conference proceedings (collections of essays) [C] , compilation [G] , Newspaper [N] , Periodical [J] , Dissertation [D] , Report [R] , Standard [S] , Patent [P] , File [B] , Ancient Books [O] , Database [DB] , Electronic Bulletin [EB] , CD [CD] , Online Network [OL] , Network Journal [J/OL] , Network Electronic Bulletin [EB/OL] , Other [Z] .

 

10. Statistical methods　The statistical processing methods of the data in the results should be described in detail as much as possible.

 

10.1. Selection of statistical analysis methods　Appropriate statistical analysis methods should be selected according to the type of design used, the conditions of the data and the purpose of analysis.

 

10.2. Statistical symbols　Write according to the relevant provisions of GB3358-82 "Statistical Terms and Symbols", commonly used as follows: (1) The arithmetic mean of the sample is in lowercase English x, and the median is in M; (2) Standard deviation is in English lowercase s; (3) Standard Misuse of English Capital SE; (4) English lowercase t for t test; (5) English uppercase F for F test; (6) Chi-square test for χ²; (7) English lowercase r for correlation coefficient ; (8) The degree of freedom is written in Greek lowercase υ; (9) The probability is written in English capital P.

 

10.3. The expression and description of data　Quantitative data that obeys an approximate normal distribution are represented by (x±s), and quantitative data with skewed distribution is represented by M (QR) ; when expressed by relative numbers, the denominator should not be less than 20, and attention should be paid to distinguish between percentage.

 

10.4. Interpretation and expression of statistical results　when P<0.05 (or P<0.01), it should be said that the difference between the comparison groups is statistically significant, and the specific name of the statistical analysis method used (such as: t Test, analysis of variance of two-factor factorial design data, q test for pairwise comparisons between multiple group means, etc.) , specific values of statistics (such as: t=3.45, χ²=4.68, F=6.79, etc.) . When it comes to overall parameters (such as overall mean, overall rate, etc.), a 95% confidence interval (95%CI) should be given at the same time as the significance test result.

 

11. Charts/Figures　Charts are coded consecutively according to the order in which they appear in the text. The full text has only 1 picture when the order of the picture is written as Figure 1, and only 1 table when the order of the table is written as Table 1. Each figures (table) should be capped with a figure (table) title in both Chinese and English. The figure (table) title should be concise and reflect the content of the figure (table). Please use the plain text format for the figure title. Do not use the image format. It is descriptive the information should be placed under the figure (table) for notes. The gross specimen photos should be marked with scales in the figure; the pathological photos should indicate the staining method and magnification.

The figure (table) should be self-explanatory, and the content of the figure (table) cannot be duplicated with the text of the main text and the content of the table (figure). The table should be designed according to the principles of statistical tabulation, and strive to be simple in structure. There should be a logical subject-predicate relationship between the horizontal and vertical headings. The subject is generally placed on the left side of the table, and the predicate is generally placed on the right side of the table.

This journal uses a three-line table (top line, header line, bottom line). If there is a total or statistical processing line (such as t-value, P-value, etc.), add a dividing line above this line; the parameters in the table should be Mark the unit; the numbers in the table require the same effective digits of the same index. Generally, the effective digits are determined by 1/3 of the standard deviation. If there is a reference value, please be consistent with the reserved effective digits of the reference value. There should be no blanks in the table. If there is no item, or if it is not detected or found, it should be indicated by "－", and the situation should be described in the form of a note below the table. "0" means that the actual measurement result is zero.

 

12. Units of measurement　Implement the provisions on quantities, units, and symbols in GB3100-3102-1993 "Quantities and Units". When there are more than one diagonal lines indicating division in the combined unit symbol, it should be expressed in the form of negative powers, such as ng/kg/min should be in the form of ng·kg^-1·min^-1. The unit of measurement for blood pressure is millimeter mercury (mmHg) .

 

13. Numbers　Implement GB/T 15835-2011 "Regulations on the Use of Numbers in Publications".

 

14. Medical terms　Medical terms should use terms promulgated by the National Scientific and Technical Terms Review Committee. Subject terms that have not yet passed the verification can be selected from the subject terms in the latest edition of "Medical Subject Thesaurus (MeSH)", "Medical Subject Terms Annotated Words" and "Chinese Medicine Subject Terms List". For nouns that do not have a universal translation, the original word should be indicated at the first occurrence in the text. The names of Chinese and Western medicines are subject to the latest editions of "The Pharmacopoeia of the People's Republic of China" and "Generic Names of Chinese Medicines" (both prepared by the Chinese Pharmacopoeia Committee) . The English drug names are international non-patent drug names. The name of a drug is generally not allowed to use a trade name, and the general name of the trade name should be indicated first when it is really necessary to use a trade name. Minimize the use of abbreviations in the text. The full name must be stated at the first occurrence, and then the Chinese abbreviation or the English full name and abbreviations should be indicated in parentheses.

 

Other requirements

 

1　When submitting the manuscript, please attach the first author's information, including name, title, highest education, research direction, work unit and detailed mailing address, contact phone number, postal code, E-mail, etc., so that the editorial department can be contacted.

 

2　Manuscript format　Manuscripts are required to be fluent in sentences. Special languages, upper and lower corner symbols, italics, etc. should be noted. Manuscripts should be submitted online in Word format. Please submit to the official website of Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease (http: //www.syxnf.net) .

 

3　Acceptance and publication　Any manuscript that has not been notified of the processing of the manuscript within 2 months after receiving the receipt of this journal is still under review. If the author wants to submit to another journal, please contact the journal first. Do not make two manuscripts cast. Papers that have been published in non-public journals, or exchanged at academic conferences, or have been published in other languages (with the consent of the first-published journal), do not belong to one manuscript and two submissions, but must be noted when submitting the manuscript. Authors can log on to our website to check the progress of manuscript processing in time. For papers that can be published after the third review, the editorial department will send a notice of page fee payment to the author's mailbox and notify the author by telephone.

 

4　All contributions are at their own risk　In accordance with the relevant provisions of the "Copyright Law", this journal may modify or abridge the text of contributions. Any amendments that involve the original intent shall be submitted to the author for consideration.

 

5　Copyright　Once the copyrighted manuscript is adopted, the author needs to sign the Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease paper copyright exclusive license and exclusive agency authorization letter, authorizing the copyright of the paper and related property rights to belong to the Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease. The agency has the exclusive right to use part or all of the paper, the right to compile (part or all of the article), the right to print and copy the electronic version, the right to translate, the right to network dissemination, the right to exhibit, the right to distribute, and the licensing of domestic and foreign document retrieval systems or access to the database (including: CNKI, Wanfang Knowledge Data Service platform, Weipu network, Superstar, Longyuan Journal network) . Without the permission of the Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease, no part of this paper may be reprinted elsewhere. If the original text is properly quoted or used in non-commercial and other circumstances that comply with the license, its use, dissemination and reproduction are permitted.

 

Contact us

 

Address: 050071 299 Heping West Road, Shijiazhuang 050071, China  Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease Editorial Department

E-mail: syxnfxgbzz@chinagp.net.cn

Tel: 0310-2067168; 18833006545

Online submission website: http://www.syxnf.net